Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
Alexis Browning
Ricki Fairley: Surviving and Thriving After Triple Negative Breast Cancer
Trevor Maxwell – Man Up to Cancer
Bringing Cancer Research to Life: Elizabeth M. Jaffee, MD, FAACR
Drugging the Elusive KRAS
Translating Personal Tragedy Into the Search for New Cancer Therapeutics
Medicare’s ABCDs with Kate Yandell and Juliette Cubanski
Lanette Veres-Handle With Care
Follow My Lead
A monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.
by Sandra Gordon
Immunotherapy Improves Survival in Bladder CancerNew research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
The AACR’s immuno-oncology meeting brings together the leading experts in immunotherapy to accelerate progress in cancer science and medicine.
The Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
